Veljanoski v. Juno Therapeutics, Inc. et al

Filing 108

STIPULATED PROTECTIVE ORDER signed by Judge Ricardo S Martinez. (PM)

Download PDF
1 2 3 4 5 6 UNITED STATES DISTRICT COURT 7 WESTERN DISTRICT OF WASHINGTON AT SEATTLE 8 9 CASE NO.: C16-1069 RSM 10 11 STIPULATED PROTECTIVE ORDER 12 13 In re JUNO THERAPEUTICS, INC. 14 15 16 17 18 19 20 21 22 23 24 25 26 27 STIPULATED PROTECTIVE ORDER NO. C16-1069 RSM CRAVATH, SWAINE AND MOORE LLP 825 Eighth Avenue, New York, NY 10019-7475 Tel: (212) 474-1000 • Fax: (212) 474-3700 1 In connection with the production of confidential documents and other confidential 2 information in this action, Plaintiffs Gilbert Hoang Nguyen and Susan Tan and Defendants Juno 3 Therapeutics, Inc. (“Juno”), Hans E. Bishop, Steven D. Harr, and Mark J. Gilbert, through their 4 respective counsel, enter into this Stipulated Protective Order for the Treatment of Designated 5 Information. 6 1. PURPOSES AND LIMITATIONS 7 Discovery in this action is likely to involve production of confidential, proprietary, or 8 private information for which special protection may be warranted. Accordingly, the parties hereby 9 stipulate to and petition the Court to enter the following Stipulated Protective Order. The purpose 10 of this Stipulated Protective Order is to provide a means for limiting access to, use, and disclosure 11 of confidential material (as defined below) produced in this action while affording public 12 disclosure to the greatest extent possible. The parties acknowledge that this agreement is consistent 13 with LCR 26(c). It does not confer blanket protection on all disclosures or responses to discovery, 14 the protection it affords from public disclosure and use extends only to the limited information or 15 items that are entitled to confidential treatment under the applicable legal principles, and it does 16 not presumptively entitle parties to file confidential material (as defined below) under seal. 17 2. 18 19 20 “CONFIDENTIAL” MATERIAL “Confidential” material shall include the following documents, deposition testimony, information, and other tangible or intangible items produced or otherwise exchanged: (i) non-public intellectual property or proprietary information, including, but 21 not limited to, research, data, technical specifications, designs, processes, production methods, 22 cost or pricing regarding any Juno product, or any communications concerning the foregoing; 23 24 25 26 27 (ii) non-public communications concerning development, testing, or analyses of pre-clinical and clinical-stage pharmaceutical products; (iii) non-public communications with any governmental regulatory or supervisory agency, body or group; (iv) non-public clinical study data and analyses; STIPULATED PROTECTIVE ORDER NO. C16-1069 RSM -1- CRAVATH, SWAINE AND MOORE LLP 825 Eighth Avenue, New York, NY 10019-7475 Tel: (212) 474-1000 • Fax: (212) 474-3700 (v) 1 non-public information pertaining or referring to Juno’s regulatory, 2 financial, business development or marketing plans or practices that, if disclosed, could damage 3 Juno’s competitive position; (vi) 4 non-public information obtained from a non-party pursuant to a non- 5 disclosure agreement, or that the producing party is under a legal or contractual obligation to 6 maintain as confidential; 7 (vii) non-public personal, medical or financial information; or 8 (viii) non-public terms of commercial agreements, licensing agreements, 9 collaboration agreements, clinical trial agreements, sponsored research agreements, settlement 10 agreements or communications pertaining to such agreements. 11 3. SCOPE 12 The protections conferred by this agreement cover not only confidential material (as 13 defined above), but also (1) any information copied or extracted from confidential material; (2) all 14 copies, excerpts, summaries, or compilations of confidential material; and (3) any testimony, 15 conversations, or presentations by parties or their counsel that might reveal confidential material. 16 However, the protections conferred by this agreement do not cover information that is in 17 the public domain or becomes part of the public domain through trial or otherwise. 18 4. 19 ACCESS TO AND USE OF CONFIDENTIAL MATERIAL 4.1 Basic Principles. A receiving party may use confidential material that is disclosed 20 or produced by another party or by a non-party in connection with this case only for prosecuting, 21 defending, or attempting to settle this litigation. Confidential material may be disclosed only to 22 the categories of persons and under the conditions described in this agreement. Confidential 23 material must be stored and maintained by a receiving party at a location and in a secure manner 24 that ensures that access is limited to the persons authorized under this agreement. 25 4.2 Disclosure of “CONFIDENTIAL” Material. Unless otherwise ordered by the Court 26 or permitted in writing by the designating party, a receiving party may disclose confidential 27 material only to: STIPULATED PROTECTIVE ORDER NO. C16-1069 RSM -2- CRAVATH, SWAINE AND MOORE LLP 825 Eighth Avenue, New York, NY 10019-7475 Tel: (212) 474-1000 • Fax: (212) 474-3700 (a) 1 2 of counsel to whom it is reasonably necessary to disclose the information for this litigation; (b) 3 4 the officers, directors, and employees (including in-house counsel) of the receiving party to whom disclosure is reasonably necessary for this litigation; (c) 5 6 the receiving party’s counsel of record in this action, as well as employees experts and consultants to whom disclosure is reasonably necessary for this litigation and who have signed the “Acknowledgment and Agreement to Be Bound” (Exhibit A); 7 (d) the Court, court personnel, and court reporters and their staff; 8 (e) copy or imaging services retained by counsel to assist in the duplication of 9 confidential material, provided that counsel for the party retaining the copy or imaging service 10 instructs the service not to disclose any confidential material to third parties and to immediately 11 return all originals and copies of any confidential material; (f) 12 during their depositions, any witness to whom disclosure is reasonably 13 necessary who is not otherwise permitted to view confidential material pursuant to this agreement 14 and who has signed the “Acknowledgment and Agreement to Be Bound” (Exhibit A), unless 15 otherwise agreed by the designating party or ordered by the Court. Pages of transcribed deposition 16 testimony or exhibits to depositions that reveal confidential material must be separately bound by 17 the court reporter and may not be disclosed to anyone except as permitted under this agreement; (g) 18 19 the author or recipient of a document containing the information or a custodian or other person who otherwise possessed or knew the information; or (h) 20 any mediator who the parties agree to use in the event the parties pursue 21 mediation, and any such mediator’s employees to whom disclosure is reasonably necessary for the 22 mediation. 23 4.3 Filing Confidential Material. Before filing confidential material or discussing or 24 referencing such material in court filings, the filing party shall confer with the designating party 25 to determine whether the designating party will remove the confidential designation, whether the 26 document can be redacted, or whether a motion to seal or stipulation and proposed order is 27 STIPULATED PROTECTIVE ORDER NO. C16-1069 RSM -3- CRAVATH, SWAINE AND MOORE LLP 825 Eighth Avenue, New York, NY 10019-7475 Tel: (212) 474-1000 • Fax: (212) 474-3700 1 warranted. Local Civil Rule 5(g) sets forth the procedures that must be followed and the standards 2 that will be applied when a party seeks permission from the Court to file material under seal. 3 5. 4 DESIGNATING PROTECTED MATERIAL 5.1 Exercise of Restraint and Care in Designating Material for Protection. Each party 5 or non-party that designates information or items for protection under this agreement must take 6 care to limit any such designation to specific material that qualifies under the appropriate 7 standards. The designating party must designate for protection only those parts of material, 8 documents, items, or oral or written communications that qualify, so that other portions of the 9 material, documents, items, or communications for which protection is not warranted are not swept 10 unjustifiably within the ambit of this agreement. 11 Mass, indiscriminate, or routinized designations are prohibited. Designations that are 12 shown to be clearly unjustified or that have been made for an improper purpose (e.g., to 13 unnecessarily encumber or delay the case development process or to impose unnecessary expenses 14 and burdens on other parties) expose the designating party to sanctions. 15 If it comes to a designating party’s attention that information or items that it designated for 16 protection do not qualify for protection, the designating party must promptly notify all other parties 17 that it is withdrawing the mistaken designation. 18 5.2 Manner and Timing of Designations. Except as otherwise provided in this 19 agreement (see, e.g., section 5.2(a)), or as otherwise stipulated or ordered, disclosure or discovery 20 material that qualifies for protection under this agreement must be clearly so designated before or 21 when the material is disclosed or produced. 22 (a) Information in documentary form: (e.g., paper or electronic documents and 23 deposition exhibits, but excluding transcripts of depositions or other pretrial or trial proceedings) 24 the designating party must affix the word “CONFIDENTIAL” to each page that contains 25 confidential material. If only a portion or portions of the material on a page qualifies for protection, 26 the producing party also must clearly identify the protected portion(s) (e.g., by making appropriate 27 markings in the margins). STIPULATED PROTECTIVE ORDER NO. C16-1069 RSM -4- CRAVATH, SWAINE AND MOORE LLP 825 Eighth Avenue, New York, NY 10019-7475 Tel: (212) 474-1000 • Fax: (212) 474-3700 (b) 1 Testimony given in deposition or in other pretrial proceedings: the parties 2 and any participating non-parties must identify on the record, during the deposition or other pretrial 3 proceeding, all protected testimony, without prejudice to their right to so designate other testimony 4 after reviewing the transcript. Any party or non-party may, within fifteen days after receiving the 5 transcript of the deposition or other pretrial proceeding, designate portions of the transcript, or 6 exhibits thereto, as confidential. If a party or non-party desires to protect confidential material at 7 trial, the issue should be addressed during the pre-trial conference. (c) 8 Other tangible items: the producing party must affix in a prominent place 9 on the exterior of the container or containers in which the information or item is stored the word 10 “CONFIDENTIAL.” If only a portion or portions of the information or item warrant protection, 11 the producing party, to the extent practicable, shall identify the protected portion(s). 5.3 12 Inadvertent Failures to Designate. If timely corrected, an inadvertent failure to 13 designate qualified information or items does not, standing alone, waive the designating party’s 14 right to secure protection under this agreement for such material. Upon timely correction of a 15 designation, the receiving party must make reasonable efforts to ensure that the material is treated 16 in accordance with the provisions of this agreement. 17 6. 18 CHALLENGING CONFIDENTIALITY DESIGNATIONS 6.1 Timing of Challenges. Any party or non-party may challenge a designation of 19 confidentiality at any time. Unless a prompt challenge to a designating party’s confidentiality 20 designation is necessary to avoid foreseeable, substantial unfairness, unnecessary economic 21 burdens, or a significant disruption or delay of the litigation, a party does not waive its right to 22 challenge a confidentiality designation by electing not to mount a challenge promptly after the 23 original designation is disclosed. 24 6.2 Meet and Confer. The parties must make every attempt to resolve any dispute 25 regarding confidential designations without court involvement. Any motion regarding confidential 26 designations or for a protective order must include a certification, in the motion or in a declaration 27 or affidavit, that the movant has engaged in a good faith meet and confer conference with other STIPULATED PROTECTIVE ORDER NO. C16-1069 RSM -5- CRAVATH, SWAINE AND MOORE LLP 825 Eighth Avenue, New York, NY 10019-7475 Tel: (212) 474-1000 • Fax: (212) 474-3700 1 affected parties in an effort to resolve the dispute without court action. The certification must list 2 the date, manner, and participants to the conference. A good faith effort to confer requires a face- 3 to-face meeting or a telephone conference. 6.3 4 Judicial Intervention. If the parties cannot resolve a challenge without court 5 intervention, the designating party may file and serve a motion to retain confidentiality under Local 6 Civil Rule 7 (and in compliance with Local Civil Rule 5(g), if applicable). The burden of 7 persuasion in any such motion shall be on the designating party. Frivolous challenges, and those 8 made for an improper purpose (e.g., to harass or impose unnecessary expenses and burdens on 9 other parties) may expose the challenging party to sanctions. All parties shall continue to maintain 10 the material in question as confidential until the Court rules on the challenge. 11 7. 12 If a party is served with a subpoena or a court order issued in other litigation that compels 13 14 15 disclosure of any information or items designated in this action as “CONFIDENTIAL,” that party must: (a) 16 17 20 (b) 23 24 25 26 27 promptly notify in writing the party who caused the subpoena or order to issue in the other litigation that some or all of the material covered by the subpoena or order is subject to this agreement. Such notification shall include a copy of this agreement; and (c) 21 22 promptly notify the designating party in writing and include a copy of the subpoena or court order; 18 19 PROTECTED MATERIAL SUBPOENAED OR ORDERED PRODUCED IN OTHER LITIGATION cooperate with respect to all reasonable procedures sought to be pursued by the designating party whose confidential material may be affected. 8. UNAUTHORIZED DISCLOSURE OF PROTECTED MATERIAL If a receiving party learns that, by inadvertence or otherwise, it has disclosed confidential material to any person or in any circumstance not authorized under this agreement, the receiving party must immediately (a) notify in writing the designating party of the unauthorized disclosures, (b) use its best efforts to retrieve all unauthorized copies of the protected material, (c) inform the STIPULATED PROTECTIVE ORDER NO. C16-1069 RSM -6- CRAVATH, SWAINE AND MOORE LLP 825 Eighth Avenue, New York, NY 10019-7475 Tel: (212) 474-1000 • Fax: (212) 474-3700 1 person or persons to whom unauthorized disclosures were made of all the terms of this agreement, 2 and (d) request that such person or persons execute the “Acknowledgment and Agreement to Be 3 Bound” that is attached hereto as Exhibit A. 4 9. 5 8 9 10 11 12 13 14 15 16 17 18 19 20 OF PRIVILEGED OR OTHERWISE When a producing party gives notice to receiving parties that certain inadvertently 6 7 INADVERTENT PRODUCTION PROTECTED MATERIAL produced material is subject to a claim of privilege or other protection, the obligations of the receiving parties are those set forth in Federal Rule of Civil Procedure 26(b)(5)(B). This provision does not, however, alter the provisions of the parties’ Stipulation Regarding Discovery of Electronically Stored Information. The parties agree to the entry of a non-waiver order under Fed. R. Evid. 502(d) as set forth herein. 10. NON TERMINATION AND RETURN OF DOCUMENTS Within 60 days after the termination of this action, including all appeals, each receiving party must either return or destroy all confidential material to the producing party, including all copies, extracts, and summaries thereof. Notwithstanding this provision, counsel are entitled to retain one archival copy of all documents filed with the Court; trial, deposition, and hearing transcripts; correspondence; deposition and trial exhibits; expert reports; attorney work product; and consultant and expert work product, even if such materials contain confidential material. The confidentiality obligations imposed by this agreement shall remain in effect until a designating party agrees otherwise in writing or a court orders otherwise. 21 22 23 IT IS SO STIPULATED, THROUGH COUNSEL OF RECORD. DATED: November 30, 2017 s/ Omar Jafri Attorneys for Plaintiff DATED: November 30, 2017 s/ Lauren Rosenberg Attorneys for Defendant 24 25 26 27 PURSUANT TO STIPULATION, IT IS SO ORDERED. STIPULATED PROTECTIVE ORDER NO. C16-1069 RSM -7- CRAVATH, SWAINE AND MOORE LLP 825 Eighth Avenue, New York, NY 10019-7475 Tel: (212) 474-1000 • Fax: (212) 474-3700 1 IT IS FURTHER ORDERED that pursuant to Fed. R. Evid. 502(d), the production of any 2 documents in this proceeding shall not, for the purposes of this proceeding or any other proceeding 3 in any other court, constitute a waiver by the producing party of any privilege applicable to those 4 documents, including the attorney-client privilege, attorney work-product protection, or any other 5 privilege or protection recognized by law. 6 7 DATED: December 18, 2017 8 9 A 10 RICARDO S. MARTINEZ CHIEF UNITED STATES DISTRICT JUDGE 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 STIPULATED PROTECTIVE ORDER NO. C16-1069 RSM -8- CRAVATH, SWAINE AND MOORE LLP 825 Eighth Avenue, New York, NY 10019-7475 Tel: (212) 474-1000 • Fax: (212) 474-3700 1 EXHIBIT A 2 ACKNOWLEDGMENT AND AGREEMENT TO BE BOUND 3 I, ____________________________________ [print or type full name], of 4 ____________________________________ [print or type full address], declare under penalty of 5 perjury that I have read in its entirety and understand the Stipulated Protective Order that was 6 issued by the United States District Court for the Western District of Washington on [date] in the 7 case of In re Juno Therapeutics, Inc., No. C16-1069 RSM. I agree to comply with and to be bound 8 by all the terms of this Stipulated Protective Order and I understand and acknowledge that failure 9 to so comply could expose me to sanctions and punishment in the nature of contempt. I solemnly 10 promise that I will not disclose in any manner any information or item that is subject to this 11 Stipulated Protective Order to any person or entity except in strict compliance with the provisions 12 of this Order. 13 I further agree to submit to the jurisdiction of the United States District Court for the 14 Western District of Washington for the purpose of enforcing the terms of this Stipulated Protective 15 Order, even if such enforcement proceedings occur after termination of this action. 16 Date: 17 City and State where sworn and signed: 18 Printed name: 19 Signature: 20 21 22 23 24 25 26 27 STIPULATED PROTECTIVE ORDER NO. C16-1069 RSM -9- CRAVATH, SWAINE AND MOORE LLP 825 Eighth Avenue, New York, NY 10019-7475 Tel: (212) 474-1000 • Fax: (212) 474-3700 1 Dated: November 30, 2017 2 3 4 5 s/ Gregory L. Watts Gregory L. Watts, WSBA #43995 WILSON SONSINI GOODRICH & ROSATI, PC 701 Fifth Avenue, Suite 5100 Seattle, Washington 98104 Tel: (206) 883-2500 Fax: (206) 883-2699 gwatts@wsgr.com Nina F. Locker, pro hac vice Ignacio E. Salceda, pro hac vice Joni Ostler, pro hac vice 650 Page Mill Road Palo Alto, CA 94304 Tel: (650) 849-3457 Fax: (650) 493-6811 nlocker@wsgr.com isalceda@wsgr.com jostler@wsgr.com 6 7 8 9 10 11 Daniel Slifkin Karin A. DeMasi Lauren M. Rosenberg CRAVATH, SWAINE & MOORE LLP 825 Eighth Avenue New York, NY 10019 Tel: (212) 474-1000 Fax: (212) 474-3700 dslifkin@cravath.com kdemasi@cravath.com lrosenberg@cravath.com 12 13 14 15 16 17 Attorney for Defendants Juno Therapeutics, Inc., Hans E. Bishop, Steven D. Harr, and Mark J. Gilbert 18 19 20 s/ Cliff Cantor 21 22 By: Cliff Cantor, WSBA # 17893 LAW OFFICES OF CLIFFORD A. CANTOR, P.C. 627 208th Ave. SE Sammamish, WA 98074 Tel: (425) 868-7813 Fax: (425) 732-3752 cliff.cantor@outlook.com Plaintiffs’ Liaison Counsel 23 24 25 26 27 STIPULATED PROTECTIVE ORDER NO. C16-1069 RSM -10- CRAVATH, SWAINE AND MOORE LLP 825 Eighth Avenue, New York, NY 10019-7475 Tel: (212) 474-1000 • Fax: (212) 474-3700 1 POMERANTZ LLP Patrick V. Dahlstrom Leigh H. Smollar Omar Jafri Ten South La Salle Street, Suite 3505 Chicago, Illinois 60603 Tel: (312) 377-1181 Fax: (312) 377-1184 pdahlstrom@pomlaw.com lsmollar@pomlaw.com ojafri@pomlaw.com 2 3 4 5 6 7 8 POMERANTZ LLP Jeremy A. Lieberman J. Alexander Hood II 600 Third Avenue, 20th Floor New York, New York 10016 Tel: (212) 661-1100 Fax: (212) 661-8665 jalieberman@pomlaw.com ahood@pomlaw.com Plaintiffs’ Lead Counsel 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 STIPULATED PROTECTIVE ORDER NO. C16-1069 RSM -11- CRAVATH, SWAINE AND MOORE LLP 825 Eighth Avenue, New York, NY 10019-7475 Tel: (212) 474-1000 • Fax: (212) 474-3700 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?